ValueWorks’s Gilead Sciences GILD Stock Holding History

ValueWorks’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,903	Closed	-$1.93M	–	34
2024 Q4	$1.93M	Sell	20,903 -7,970	-28%	-$718K	0.64%	31
2024 Q3	$2.42M	Sell	28,873 -174	-0.6%	-$13.3K	0.77%	31
2024 Q2	$1.99M	Buy	29,047 +150	+0.5%	+$10K	0.62%	30
2024 Q1	$2.12M	Sell	28,897 -150	-0.5%	-$11.5K	0.69%	30
2023 Q4	$2.35M	Sell	29,047 -91	-0.3%	-$7.08K	0.8%	29
2023 Q3	$2.18M	Sell	29,138 -2,019	-6%	-$155K	0.79%	29
2023 Q2	$2.4M	Sell	31,157 -419	-1%	-$33.4K	0.87%	29
2023 Q1	$2.62M	Buy	31,576 +38	+0.1%	+$3.15K	1%	28
2022 Q4	$2.71M	Sell	31,538 -9,050	-22%	-$717K	0.96%	28
2022 Q3	$2.5M	Buy	40,588 +86	+0.2%	+$5.42K	1.02%	29
2022 Q2	$2.5M	Buy	40,502 +442	+1%	+$27.4K	1.03%	30
2022 Q1	$2.38M	Sell	40,060 -381	-0.9%	-$24.4K	0.78%	31
2021 Q4	$2.94M	Sell	40,441 -124	-0.3%	-$8.54K	1.16%	28
2021 Q3	$2.83M	Buy	40,565 +1	+0%	+$70	1.21%	28
2021 Q2	$2.79M	Buy	40,564 +776	+2%	+$51.8K	1.2%	27
2021 Q1	$2.57M	Buy	39,788 +52	+0.1%	+$3.35K	1.46%	22
2020 Q4	$2.31M	Sell	39,736 -1,945	-5%	-$117K	1.48%	24
2020 Q3	$2.63M	Sell	41,681 -11,395	-21%	-$790K	2.22%	20
2020 Q2	$4.08M	Sell	53,076 -10,350	-16%	-$793K	3.5%	14
2020 Q1	$4.74M	Sell	63,426 -31,162	-33%	-$2.15M	4.61%	10
2019 Q4	$6.15M	Buy	94,588 +32,144	+51%	+$2.09M	3.84%	10
2019 Q3	$3.96M	Sell	62,444 -7,249	-10%	-$474K	2.69%	20
2019 Q2	$4.71M	Buy	69,693 +8,347	+14%	+$549K	3.1%	18
2019 Q1	$3.99M	Buy	61,346 +3,955	+7%	+$263K	2.67%	20
2018 Q4	$3.59M	Sell	57,391 -9,680	-14%	-$677K	2.47%	21
2018 Q3	$5.18M	Sell	67,071 -2,821	-4%	-$213K	3.28%	18
2018 Q2	$4.95M	Buy	+69,892	New	+$4.94M	3.17%	20
2018 Q1	–	Sell	-69,581	Closed	-$4.99M	–	27
2017 Q4	$4.99M	Sell	69,581 -2,327	-3%	-$177K	3.71%	15
2017 Q3	$5.83M	Buy	71,908 +430	+0.6%	+$32.9K	4.14%	10
2017 Q2	$5.06M	Sell	71,478 -114	-0.2%	-$7.59K	3.79%	13
2017 Q1	$4.86M	Sell	71,592 -1,105	-2%	-$77.7K	3.74%	13
2016 Q4	$5.21M	Sell	72,697 -114	-0.2%	-$8.47K	4.1%	10
2016 Q3	$5.76M	Sell	72,811 -752	-1%	-$61.1K	5.12%	6
2016 Q2	$6.14M	Buy	73,563 +8,003	+12%	+$710K	5.22%	4
2016 Q1	$6.02M	Buy	65,560 +4,628	+8%	+$417K	5.15%	7
2015 Q4	$6.17M	Sell	60,932 -2,947	-5%	-$307K	5.03%	8
2015 Q3	$6.27M	Sell	63,879 -41,773	-40%	-$4.64M	4.41%	10
2015 Q2	$12.4M	Sell	105,652 -1,173	-1%	-$128K	7.02%	2
2015 Q1	$10.5M	Sell	106,825 -525	-0.5%	-$53.3K	5.51%	3
2014 Q4	$10.1M	Buy	+107,350	New	+$11.1M	4.99%	4

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ValueWorks's GILD Position: Q1 2025 in Review

ValueWorks sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 20,903 shares — an estimated $1.93M sold.

ValueWorks first reported a position in GILD in Q4 2014 and held it in 40 quarters. The position peaked at $12.4M in Q2 2015. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

ValueWorks reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
ValueWorks sold 20,903 Gilead Sciences shares in Q1 2025, an estimated $1.93M.
ValueWorks first reported a position in Gilead Sciences in Q4 2014 and held it in 40 quarters.
ValueWorks's Gilead Sciences position peaked at $12.4M in Q2 2015.
2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on ValueWorks's 13F filing for Q1 2025, filed 14 May 2025.